Clinical and rehabilitation aspects of managing patients with meningiomas, schwannomas, ependymomas, and pituitary neuroendocrine tumors

The rehabilitation of neurooncology patients represents a critical issue due to the high incidence of brain tumors of varying locations and the severity of associated neurological symptoms, which significantly reduce the patient’s quality of life. Over the past decades, the prevalence of central nervous system tumor has increased by more than twofold in individuals aged 65 and above. Neurooncology patients represent a complex group that requires long-term restorative treatment. The early initiation of rehabilitation facilitates the recovery of impaired functions prior to the formation of persistent pathological patterns. This article examines neurorehabilitation methods using the example of the most common benign brain tumors, which include meningiomas, schwannomas, ependymomas, and pituitary neuroendocrine tumors. Significant advancements have been made in the treatment of these tumors in recent years, particularly through combined treatment modalities. A multidisciplinary approach to neurooncology is becoming increasingly recognized as a key element in global healthcare. However, the needs of these patients and their families extend beyond medical care, necessitating the involvement of psychologists, occupational therapists, speech-language pathologists, and social workers. A comprehensive approach to treatment, early restorative interventions and the development of innovative neurorehabilitation methods can facilitate a personalized strategy for patients with benign brain tumors, thereby increasing their rehabilitation potential.

1. Rehabilitation. World Health Organization. Available at: https://www.who.int/news-room/fact-sheets/detail/rehabilitation (accessed 11.06.2024).

2. Vasilenko A.V., Lavrik M.Т., Grigoreva P.A. Current methods of postsurgical rehabilitation in benign brain tumor patients. Reabilitologiya / Rehabilitology. 2024; 2 (2): 197–206 (in Russ.). https://doi.org/10.17749/2949-5873/rehabil.2024.8.

3. Ulitin A.Yu., Olyushin V.E., Kondakov E.N., et al. Epidemiology of brain tumors in some regions of Russia. Siberian Journal of Oncology. 2006; S1: 129–30 (in Russ.).

4. Karyagina M.V., Ivanova N.E., Tereshin A.E., et al. The results of surgery for benign tumors after inpatient rehabilitation. Bulletin of Rehabilitation Medicine. 2017; 16 (6): 61–7 (in Russ.).

5. Fouda M.A., Sacks-Zimmerman A., Mascialino G., et al. Utilization of a Cogmed working memory training program in patients with neurocognitive impairment following the resection of intracranial meningioma: case series and review of the literature. Interdis Neurosurg. 2023; 34: 101856. https://doi.org/10.1016/j.inat.2023.101856.

6. Han S., Yang Y., Yang Z., et al. Continuous progression of hemorrhage of sphenoid ridge meningioma causing cerebral hernia: a case report and literature review. Oncol Lett. 2020; 20 (1): 785–93. https://doi.org/10.3892/ol.2020.11590.

7. Ullah S., Qureshi A.Z., Rathore F.A., et al. Functional outcomes of patients with primary brain tumors undergoing inpatient rehabilitation at a tertiary care rehabilitation facility in Saudi Arabia. Int J Environ Res Public Health. 2023; 20 (6): 4679. https://doi.org/10.3390/ijerph20064679.

8. Weyer-Jamora C., Brie M.S., Luks T.L., et al. Postacute cognitive rehabilitation for adult brain tumor patients. Neurosurgery. 2021; 89 (6): 945–53. https://doi.org/10.1093/neuros/nyaa552.

9. Loomis E., Wakasa M. Rehabilitation from meningioma. Handb Clin Neurol. 2020; 170: 323–31. https://doi.org/10.1016/B978-0-12822198-3.00051-3.

10. Królikowska A., Filipska-Blejder K., Jabłońska R., et al. Quality of life after surgical treatment of brain tumors. J Clin Med. 2022; 11 (13): 3733. https://doi.org/10.3390/jcm11133733.

11. Nicholson C., Edwards M.J., Carson A.J., et al. Occupational therapy consensus recommendations for functional neurological disorder. J Neurol Neurosurg Psychiatry. 2020; 91 (10): 1037–45. https://doi.org/10.1136/jnnp-2019-322281.

12. Espay A.J., Aybek S., Carson A., et al. Current concepts in diagnosis and treatment of functional neurological disorders. JAMA Neurol. 2018; 75 (9): 1132–41. https://doi.org/10.1001/jamaneurol.2018.1264.

13. Kielhofner G. A model of human occupation: theory and application. 3rd ed. Lippincott Williams & Wilkins; 2002: 576 pp.

14. Townsend E., Polatajko H.J. Enabling Occupation II: advancing an occupational therapy vision of health, well-being, and justice through occupation. CAOT Publications ACE; 2007: 418 pp.

15. Maggio M.G., Naro A., Calatozzo P., et al. Rehabilitation of somatoparaphrenia with misoplegia: insights from a single casepilot study. J Integr Neurosci. 2021; 20 (2): 439–47. https://doi.org/10.31083/j.jin2002046.

16. Safran J.D., Muran J.C. Negotiating the therapeutic alliance: a relational treatment guide. 1st ed. Guilford Press; 2003: 260 pp.

17. Burlando M., Bollo B. Use of hunova for rehabilitation following severe acquired brain injury (ABI). 2019. Available at: https://www.movendo.technology/case-studies/use-of-hunova-for-rehabilitation-followingsevere-acquired-brain-injury-abi/?lang=en (accessed 11.06.2024).

18. Han D., Shen Y., Hu H., et al. Acupuncture for rehabilitation after surgery for cerebellopontine angle meningioma: a case report. Medicine. 2019; 98 (32): e16756. https://doi.org/10.1097/MD.0000000000016756.

19. Chen L., Fang J., Ma R., et al. Additional effects of acupuncture on early comprehensive rehabilitation in patients with mild to moderate acute ischemic stroke: a multicenter randomized controlled trial. BMC Complement Altern Med. 2016; 16: 226. https://doi.org/10.1186/s12906-016-1193-y.

20. Wang W.W., Xie C.L., Lu L., et al. A systematic review and metaanalysis of Baihui (GV20)-based scalp acupuncture in experimental ischemic stroke. Sci Rep. 2014; 4: 3981. https://doi.org/10.1038/srep03981.

21. Emedoli D., Arosio M., Tettamanti A., et al. Virtual reality augmented feedback rehabilitation associated to action observation therapy in buccofacial apraxia: case report. Clin Med Insights Case Rep. 2021; 14: 1179547621994579. https://doi.org/10.1177/1179547621994579.

22. Pazzaglia M., Galli G. Action observation for neurorehabilitation in apraxia. Front Neurol. 2019; 10: 309. https://doi.org/10.3389/fneur.2019.00309.

23. Van der Linden S.D., Rutten G.M., Dirven L., et al. eHealth cognitive rehabilitation for brain tumor patients: results of a randomized controlled trial. J Neurooncol. 2021; 154 (3): 315–26. https://doi.org/10.1007/s11060-021-03828-1.

24. Vasilenko A.V., Druzhinina V.E., Sebelev K.I., et al. Occipital-lobe epilepsy associated with intraparenchymal schwannoma in the occipital lobe: a modern perspective on the problem. Russian Neurosurgical Journal named after Professor A. L. Polenov. 2024; 16 (2): 138–49 (in Russ.). https://doi.org/10.56618/2071–2693_2024_16_2_138.

25. Mankekar G., Holmes S. Hearing rehabilitation in vestibular schwannoma. Audiol Res. 2023; 13 (3): 357–66. https://doi.org/10.3390/audiolres13030031.

26. Tripathi M., Deora H., Kumar N., et al. Role of bevacizumab as a prophylactic and rehabilitative treatment modality in cases of sporadic and syndromic vestibular schwannoma: fifty shades of grey! Interdis Neurosurg. 2020; 19: 100607. https://doi.org/10.1016/j.inat.2019.100607.

27. Tamura R. Current understanding of neurofibromatosis type 1, 2, and schwannomatosis. Int J Mol Sci. 2021; 22 (11): 5850. https://doi.org/10.3390/ijms22115850.

28. Shimanskiy V.N., Tanyashin S.V., Shevchenko K.V., Odamanov D.A. Surgical treatment of acoustic neuromas (vestibular schwannomas). Burdenko's Journal of Neurosurgery. 2017; 81 (3): 66–76 (in Russ.). https://doi.org/10.17116/neiro201781366-76.

29. Morselli C., Boari N., Artico M., et al. The emerging role of hearing loss rehabilitation in patients with vestibular schwannoma treated with Gamma Knife radiosurgery: literature review. Neurosurg Rev. 2021; 44 (1): 223–38. https://doi.org/10.1007/s10143-020-01257-8.

30. Zharova E.N., Bondarenko A.B., Vershinina E.A., et al. Rehabilitation of patients with facial neuropathies after surgical treatment. Izvestia of the Russian Military Medical Academy. 2021; 40 (S2): 45–51 (in Russ.).

31. Sun Z.H., Tian Y.P., Tan Y.F., et al. Effectiveness of Kinesio taping on peripheral facial paralysis: a protocol for systematic review and meta-analysis. Medicine. 2020; 99 (46): e23090. https://doi.org/10.1097/MD.0000000000023090.

32. Bagga I.K.B., Samal S. Physiotherapy rehabilitation following acoustic neuroma resection in a patient with cerebellopontine angle tumour: a case report. Cureus. 2024; 16 (2): e54208. https://doi.org/10.7759/cureus.54208.

33. Rudà R., Bruno F., Pellerino A., et al. Ependymoma: evaluation and management updates. Curr Oncol Rep. 2022; 24 (8): 985–93. https://doi.org/10.1007/s11912-022-01260-w.

34. Petrikov S.S., Solodov A.A. Diagnosis and treatment of neurogenic dysphagia in patients with acute impairment of cerebral circulation. Neurology and Rheumatology (Supplement to Consilium Medicum). 2018; 1: 21–7 (in Russ.).

35. Sasegbon A., Hamdy S. The anatomy and physiology of normal and abnormal swallowing in oropharyngeal dysphagia. Neurogastroenterol Motil. 2017; 29 (11). https://doi.org/10.1111/nmo.13100.

36. Gromova D.O., Zakharov V.V. Dysphagia after stroke. Nevrologiya, neiropsikhiatriya, psikhosomatika / Neurology, Neuropsychiatry, Psychosomatics. 2015; 7 (4): 50–6 (in Russ.). https://doi.org/10.14412/2074-2711-2015-4-50-56.

37. Goethe E.A., Gadgil N., Stormes K., et al. Predicting dysphagia in children undergoing surgery for posterior fossa tumors. Childs Nerv Syst. 2020; 36 (5): 925–31. https://doi.org/10.1007/s00381-01904468-7.

38. Panebianco M., Marchese-Ragona R., Masiero S., et al. Dysphagia in neurological diseases: a literature review. Neurol Sci. 2020; 41 (11): 3067–73. https://doi.org/10.1007/s10072-020-04495-2.

39. Nacci A., Ursino F., La Vela R., et al. Fiberoptic endoscopic evaluation of swallowing (FEES): proposal for informed consent. Acta Otorhinolaryngol Ital. 2008; 28 (4): 206–11.

40. Becker R., Nieczaj F., Egge K., et al. Functional dysphagia therapy and PEG treatment in a clinical geriatric setting. Dysphagia. 2011; 26 (2): 108–16. https://doi.org/10.1007/s00455-009-9270-8.

41. Restivo D.A., Hamdy S. Pharyngeal electrical stimulation device for the treatment of neurogenic dysphagia: technology update. Med Devices. 2018; 11: 21–6. https://doi.org/10.2147/MDER.S122287.

42. Diep D., Lam A., Ko G. A review of the evidence and current applications of portable translingual neurostimulation technology. Neuromodulation. 2021; 24 (8): 1377–87. https://doi.org/10.1111/ner.13260.

43. Cofré Lizama L.E., Bastani A., Panisset M.G., et al. A novel neuromodulation technique for the rehabilitation of balance and gait: a case study. J Clin Neurosci. 2018; 54: 140–2. https://doi.org/10.1016/j.jocn.2018.04.077.

44. Danilov Y., Paltin D. Translingual Neurostimulation (TLNS): a novel approach to neurorehabilitation. Phys Med Rehabil Int. 2017; 4 (2): 1117. https://doi.org/10.26420/physmedrehabilint.2017.1117.

45. Boughen K., Neil T., Dullemond S., et al. Cranial nerve noninvasive neuromodulation in adults with neurological conditions: protocol for a scoping review. JMIR Res Protoc. 2021; 10 (7): e29965. https://doi.org/10.2196/29965.

46. Bespalov V.G., Alexandrov V.A., Vysochina G.I., et al. The inhibiting activity of meadowsweet extract on neurocarcinogenesis induced transplacentally in rats by ethylnitrosourea. J Neurooncol. 2017; 131 (3): 459–67. https://doi.org/10.1007/s11060-016-2323-6.

47. Vasilenko A.V., Chudievich S.N., Ulitin A.Yu., et al. Epilepsy associated with pituitary neuroendocrine tumors: current status of problem and interdisciplinary approach. Medical Alphabet. 2022; 21: 43–50 (in Russ.). https://doi.org/10.33667/2078-5631-2022-21-43-50.

48. De Alcubierre D., Puliani G., Cozzolino A., et al. Pituitary adenoma consistency affects postoperative hormone function: a retrospective study. BMC Endocr Disord. 2023; 23 (1): 92. https://doi.org/10.1186/s12902-023-01334-1.

49. Beylerli O.A., Shiguang Zh., Gareev I.F., Xin Ch. Diagnosis and treatment of pituitary adenomas. Creative Surgery and Oncology. 2019; 9 (4): 311–6 (in Russ.). https://doi.org/10.24060/2076-3093-2019-9-4311-316.

50. Jane J.A. Jr., Catalino M.P., Laws E.R. Jr. Surgical treatment of pituitary adenomas. In: Feingold K.R., Anawalt B., Blackman M.R., et al. (Eds.) Endotext. Comprehensive free online endocrinology book. South Dartmouth (MA): MDText.com, Inc.; 2000. Available at: https://www.endotext.org/ (accessed 11.06.2024).

51. Hong C.S., Smith T.R. Aerobic exercise interventions to address impaired quality of life in patients with pituitary tumors. PLoS One. 2023; 18 (12): e0295907. https://doi.org/10.1371/journal.pone.0295907.

52. Lee J.A., Tak E.Y., Lim H.L., et al. Time taken to resume activities of daily living after transsphenoidal surgery for pituitary tumors. Sci Rep. 2023; 13 (1): 4132. https://doi.org/10.1038/s41598-023-31203-9.

53. Zhao X., Wang T., Sheng G., et al. The fatigue, sleep and physical activity in postoperative patients with pituitary adenoma: what we can do. Transl Cancer Res. 2020; 9 (3): 1779–86. https://doi.org/10.21037/tcr.2020.02.47.

54. Dülger E., Mut M., Erbas T., et al. Effects of combined aerobicstrength training and yoga on quality of life and related parameters in women with pituitary adenoma after surgery: a randomized crossover study. Eur J Endocrinol. 2022; 186 (6): 667–75. https://doi.org/10.1530/EJE-22-0031.

55. Bobrov A.E., Starostina E.G., Alexandrova M.M., et al. Mental disorders in patients with hormonally active pituitary adenomas. Social and Clinical Psychiatry. 2018; 28 (4): 5–10 (in Russ.).